Center-Authored Papers

Filters: Author is Dörk, Thilo  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Z
Zhao Z, Wen W, Michailidou K, Bolla MK, Wang Q, Zhang B, Long J, Shu X-O, Schmidt MK, Milne RL et al..  2016.  Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry.. Cancer causes & control : CCC. 27(5):679-693. Abstract
Zhang B, Shu X-O, Delahanty RJ, Zeng C, Michailidou K, Bolla MK, Wang Q, Dennis J, Wen W, Long J et al..  2015.  Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization.. Journal of the National Cancer Institute. 107(11) Abstract
Zeng C, Guo X, Long J, Kuchenbaecker KB, Droit A, Michailidou K, Ghoussaini M, Kar S, Freeman A, Hopper JL et al..  2016.  Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.. Breast cancer research : BCR. 18(1):64. Abstract
S
Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, Michailidou K, van Rensburg EJ et al..  2016.  PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.. Journal of medical genetics. Abstract
Song H, Ramus SJ, Tyrer J, Bolton KL, Gentry-Maharaj A, Wozniak E, Anton-Culver H, Chang-Claude J, Cramer DW, DiCioccio R et al..  2009.  A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.. Nature genetics. 41(9):996-1000. Abstract
Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC et al..  2013.  Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.. Nature communications. 4:1628. Abstract
Schmidt MK, Hogervorst F, van Hien R, Cornelissen S, Broeks A, Adank MA, Meijers H, Waisfisz Q, Hollestelle A, Schutte M et al..  2016.  Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 34(23):2750-60. Abstract
P
Phelan CM, Kuchenbaecker KB, Tyrer JP, Kar SP, Lawrenson K, Winham SJ, Dennis J, Pirie A, Riggan MJ, Chornokur G et al..  2017.  Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.. Nature genetics. Abstract
Pharoah PDP, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS et al..  2011.  The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(11):3742-50. Abstract
Pharoah PDP, Tsai Y-Y, Ramus SJ, Phelan CM, Goode EL, Lawrenson K, Buckley M, Fridley BL, Tyrer JP, Shen H et al..  2013.  GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.. Nature genetics. 45(4):362-70,370e1-2. Abstract
Permuth-Wey J, Lawrenson K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin H-Y, Chen AY, Tsai Y-Y, Qu X et al..  2013.  Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.. Nature communications. 4:1627. Abstract
Permuth JB, Reid B, Earp M, Chen AY, Monteiro ANA, Chen Z, Chen Z, Chenevix-Trench G, Fasching PA, Beckmann MW et al..  2016.  Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration.. Oncotarget. 7(45):72381-72394. Abstract
O
Ong J-S, Cuellar-Partida G, Lu Y, Australian Ovarian Cancer Study, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E et al..  2016.  Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study.. International journal of epidemiology. Abstract
M
Minlikeeva AN, Freudenheim JL, Cannioto RA, Eng KH, Szender BJ, Mayor P, Etter JL, Cramer DW, Diergaarde B, Doherty JA et al..  2017.  History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report.. British journal of cancer. Abstract
Minlikeeva AN, Freudenheim JL, Eng KH, Cannioto RA, Friel G, Szender BJ, Segal B, Odunsi K, Mayor P, Diergaarde B et al..  2017.  History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 26(9):1470-1473. Abstract
Michailidou K, Beesley J, Lindstrom S, Canisius S, Dennis J, Lush MJ, Maranian MJ, Bolla MK, Wang Q, Shah M et al..  2015.  Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.. Nature genetics. 47(4):373-80. Abstract
Mavaddat N, Pharoah PDP, Michailidou K, Tyrer J, Brook MN, Bolla MK, Wang Q, Dennis J, Dunning AM, Shah M et al..  2015.  Prediction of breast cancer risk based on profiling with common genetic variants.. Journal of the National Cancer Institute. 107(5) Abstract
L
Lu Y, Cuellar G, Painter JN, Nyholt D, Morris AP, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D et al..  2015.  Shared genetics underlying epidemiological association between endometriosis and ovarian cancer.. Human molecular genetics. 24(20):5955-5964. Abstract
Lee AW, Tyrer JP, Doherty JA, Stram DA, Kupryjanczyk J, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Spiewankiewicz B, Myers EJ, Chenevix-Trench G et al..  2015.  Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study.. Gynecologic oncology. 136(3):542-8. Abstract
Lawrenson K, Li Q, Kar S, Seo J-H, Tyrer J, Spindler TJ, Lee J, Chen Y, Karst A, Drapkin R et al..  2015.  Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer.. Nature communications. 6:8234. Abstract
Lawrenson K, Iversen ES, Tyrer J, Weber RP, Concannon P, Hazelett DJ, Li Q, Marks JR, Berchuck A, Lee JM et al..  2015.  Common Variants at the CHEK2 Gene Locus and Risk of Epithelial Ovarian Cancer.. Carcinogenesis. 36(11):1341-1353. Abstract
Lawrenson K, Kar S, McCue K, Kuchenbaeker K, Michailidou K, Tyrer J, Beesley J, Ramus SJ, Li Q, Delgado MK et al..  2016.  Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.. Nature communications. 7:12675. Abstract
K
Kuchenbaecker KB, Ramus SJ, Tyrer J, Lee A, Shen HC, Beesley J, Lawrenson K, McGuffog L, Healey S, Lee JM et al..  2015.  Identification of six new susceptibility loci for invasive epithelial ovarian cancer.. Nature genetics. 47(2):164-71. Abstract
Kote-Jarai Z, Easton DF, Stanford JL, Ostrander EA, Schleutker J, Ingles SA, Schaid D, Thibodeau S, Dörk T, Neal D et al..  2008.  Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(8):2052-61. Abstract
Kote-Jarai Z, Al Olama AA, Giles GG, Severi G, Schleutker J, Weischer M, Campa D, Riboli E, Key T, Gronberg H et al..  2011.  Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.. Nature genetics. 43(8):785-791. Abstract